Navigation Links
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

ffective tax rate on Non GAAP income is 2% (2008: 20%). The Non GAAP effective tax rate in the three months to June 30, 2009 was 18 percentage points lower than the corresponding period in 2008 principally due to the decrease in valuation allowances held in respect of US State tax credits and losses. Following the interpretation and analysis of the implications of new Massachusetts State tax regulations issued in Q2 2009, Shire determined during the second quarter that it was now more likely than not that these State tax credits and losses were realizable.

Equity in earnings/(losses) of equity method investees

Net earnings of equity method investees of $0.5 million were recorded for the three months to June 30, 2009 (2008: $1.9 million loss). This comprised earnings of $1.2 million from the 50% share of the anti-viral commercialization partnership with GSK in Canada (2008: $1.5 million earnings) and losses of $0.7 million, being the Company's share of losses in the GeneChem, AgeChem and EGS Funds (2008: $3.4 million loss).

Discontinued operations

The loss from discontinued operations for the three months to June 30, 2009 was $9.8 million (2008: $nil), relating to net losses on discontinued Jerini businesses which were either divested or closed during the second quarter of 2009, the loss on divestment of Jerini's Peptides business and the write-off of the fair value less costs to sell of assets previously classified as held for sale.



    Unaudited US GAAP Consolidated Balance Sheets           14

    Unaudited US GAAP Consolidated Statements of Income     15

    Unaudited US GAAP Consolidated Statements of Cash
    Flows                                                   17

    Selected Notes to the Unaudited US GAAP Financial       19
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology
2. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
3. Shire begins the year with a strong performance
4. Shire plc: Results of the Annual General Meeting Held on April 28, 2009
5. Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009
6. Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
7. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
8. Publication of Shire plcs Annual Report 2008
9. Shires Project Playground Gives Boost to Philadelphia
10. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
11. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup ... to better understand the relationship between weight management and the microbiome. The study uses ... from participants using an iPhone app. , The uBiome app is available as a ...
(Date:10/8/2015)... DIEGO , Oct. 8, 2015  Sorrento ... company developing new treatments for cancer and associated ... Executive Officer, will be presenting at the Aegis ... Las Vegas :Event:Aegis Capital Corporation 2015 Growth ... 2 room, The Encore @ The Wynn in ...
(Date:10/8/2015)... and WAYNE, Pa. , ... and technology consulting firm, has announced the call for ... Pennsylvania , majoring in a life sciences ... a two-year period. In addition, the selected Clarkston Scholar ... mentoring with Clarkston Consulting and participation in Pennsylvania Bio ...
(Date:10/8/2015)... PORTLAND, Oregon , October 8, 2015 /PRNewswire/ ... . --> Global Biologics and Biosimilars ... added a report "Global Biologics and Biosimilars Industry ... Growth, Analysis and Forecast" is a professional and ... Biosimilars industry . ) , ...
Breaking Biology Technology:
... of Interactive, to Head New Division, AUSTIN, ... growth in marketing to customers across the entire ... top 25,independent healthcare firms, has established a full-scale ... will offer clients expanded,digital capabilities, including strategy; web ...
... MedThink Communications, an,innovator in medical communications, brand ... executives to serve the company,s growing,client base ... Steven Palmisano, the new vice president of ... as it integrates creative thinking,and scientific acumen ...
... Modeling Provides Powerful Approach to Modeling Complex ... Biological Systems for Type ... Inc., a systems,biology company focused on identifying molecular mechanisms, ... announced that,its joint collaboration with Sirtris Pharmaceuticals, Inc. (Nasdaq: ...
Cached Biology Technology:
(Date:9/29/2015)... Sept. 29, 2015  iDAvatars is excited to be named ... product to market. The official announcement was recently made at ... event in San Francisco , where iDAvatars ... by IBM Watson. "It is both an honor ... companies to bring to market the cognitive power of IBM ...
(Date:9/28/2015)... NEW YORK , Sept. 28, 2015 /PRNewswire/ ... rate, respiration rate and body temperature, is an ... signs can be indicators of deterioration in a ... the hospital, vital signs are typically taken during ... eight hours. If a patient deteriorates between these ...
(Date:9/28/2015)... 28, 2015 According to a ... Software), Product (Scanner & Others), Application (Access Control & ... Others) & Geography Global - Forecast to 2020", published by ... USD 3627.90 Million by 2020, at a CAGR of ... 65 market data T ables and ...
Breaking Biology News(10 mins):
... Until recently, Etienne Benson, an assistant professor in the University ... trained his academic eye on the history of conservation of ... With his latest publication, however, he consciously chose ... and is certainly smaller. "I wanted to write about ...
... asthma isn,t one of them, shows newly published research led ... Azad, a Banting post-doctoral fellow in the Faculty of Medicine ... investigator on the findings that appeared in the British ... 20 clinical trials in Europe, Australia, New Zealand and Taiwan ...
... and their metabolites within the central nervous system ... Although neuroactive steroids have been shown to improve ... beta (Aβ) peptide-induced neurotoxicity, changes in their level ... cognitive impairment remain elusive given the limitation in ...
Cached Biology News:
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Viruses microRNA Microarray ...
... LTQ XL extends the legendary MSn performance ... generate structural information through Thermo Scientifics innovations ... LTQ XL is the only mass spectrometer ... and CID. Pulsed Q Collision Induced ...
... The reliable and compact GC-8A is Shimadzu's ... Economical and simple to use, the GC-8A ... flow control, on column injection port(s), and ... program models are available. The GC-8A is ...
... The 6820 GC system combines world-class ... Chemical QA/QC software, Agilents world-renowned support and ... consumables and supplies--a combination that lets you ... decisions based on dependable data. The Agilent ...
Biology Products: